Aardvark Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AARD Nasdaq 2836 aardvarktherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aardvark Therapeutics, Inc.

Sector Update: Healthcare Stocks Fall Late Afternoon - Oct 23rd, 2026 1:56 pm
Aardvark Therapeutics Reports Exploratory Data from the Terminated HERO and Open-Label Extension Trials - Oct 23rd, 2026 5:00 am
Aardvark Therapeutics stock surges as FDA lifts clinical hold - Oct 22nd, 2026 3:57 pm
Aardvark Therapeutics Announces FDA Has Lifted the Clinical Hold on ARD-101 for the Treatment of Prader-Willi Syndrome and Will Host Webcast to Review the Available Exploratory Phase 3 HERO/OLE Data - Oct 22nd, 2026 2:05 pm
All You Need to Know About Aardvark Therapeutics, Inc. (AARD) Rating Upgrade to Buy - Oct 21st, 2026 9:00 am
Prader-Willi Syndrome Market to Expand by 2036 as New Therapeutic Opportunities Address Unmet Clinical Needs | DelveInsight - Oct 12th, 2026 8:31 am
Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.D., MBA, to its Board of Directors - Oct 8th, 2026 6:00 am
Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Oct 2nd, 2026 2:05 pm
Aardvark Therapeutics Inc (AARD) (Q2 2026) Earnings Call Highlights: Board Re-Elected, Auditor ... - Aug 17th, 2026 11:31 am
Aardvark Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates - Aug 11th, 2026 2:53 pm
Several Insiders Invested In Aardvark Therapeutics Flagging Positive News - May 28th, 2026 4:14 am
Sector Update: Healthcare Stocks Decline Late Afternoon - May 15th, 2026 1:52 pm
Top Midday Decliners - May 15th, 2026 12:20 pm
FDA hold puts Aardvark Prader-Willi drug in limbo - May 15th, 2026 5:58 am
Aardvark Therapeutics Plans to Unblind HERO and OLE Data to Inform Path Forward Following FDA Clinical Hold - May 14th, 2026 2:01 pm
Aardvark Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates - May 7th, 2026 6:00 am
Discover 3 Promising Penny Stocks With Market Caps Over $100M - Apr 17th, 2026 6:05 am
Why Aardvark Therapeutics (AARD) Paused Late-Stage ARD-101 Trials After Cardiac Findings - Mar 29th, 2026 2:42 pm
Aardvark Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates - Mar 23rd, 2026 2:05 pm